AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia
Public ClinicalTrials.gov record NCT00474240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of the Combination of AEGR-733 (Formerly BMS201038) and Atorvastatin 20 mg vs. Monotherapy in Subjects With Moderate Hypercholesterolemia
Study identification
- NCT ID
- NCT00474240
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aegerion Pharmaceuticals, Inc.
- Industry
- Enrollment
- 157 participants
Conditions and interventions
Conditions
Interventions
- Atorvastatin 20 mg Drug
- AEGR-733 5 mg Drug
- AEGR-733 10 mg Drug
- Placebo Drug
- AEGR-733 5 mg + atorvastatin 20 mg Drug
- AEGR-733 10 mg + atorvastatin 20 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2007
- Primary completion
- Sep 30, 2008
- Completion
- Sep 30, 2008
- Last update posted
- Mar 19, 2018
2007 – 2008
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Affiliated Research Center | Huntsville | Alabama | 35801 | — |
| Jacksonville Center for Clinical research | Jacksonville | Florida | 32205 | — |
| Jacksonville Center For Clinical Research | Jacksonville | Florida | 32216 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| North Georgia Clinical Research | Woodstock | Georgia | 30189 | — |
| Radiant Research | Chicago | Illinois | 60610 | — |
| Medsphere Medical Research Center | Evansville | Indiana | 47714 | — |
| Midwest Institute for Clinical Research | Indianapolis | Indiana | 46260 | — |
| Maine Research Associates | Auburn | Maine | 04210 | — |
| Health Trends Research | Baltimore | Maryland | 21209 | — |
| Piedmont Medical Research Associates | Winston-Salem | North Carolina | 27103 | — |
| Sterling Research Group | Cincinnati | Ohio | 45246 | — |
| Coastal Carolina Research Center | Goose Creek | South Carolina | 29445 | — |
| Dallas Diabetes and Endocrine Center | Dallas | Texas | 75230 | — |
| Diabetes and Glandular Disease Research | Dallas | Texas | 78229 | — |
| Hampton Roads Center for Clinical Research | Norfolk | Virginia | 23502 | — |
| National Clinical Research | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00474240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2018 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00474240 live on ClinicalTrials.gov.